Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Astrid Keijser"'
Autor:
Joris L. Vos, Joris B. W. Elbers, Oscar Krijgsman, Joleen J. H. Traets, Xiaohang Qiao, Anne M. van der Leun, Yoni Lubeck, Iris M. Seignette, Laura A. Smit, Stefan M. Willems, Michiel W. M. van den Brekel, Richard Dirven, M. Baris Karakullukcu, Luc Karssemakers, W. Martin C. Klop, Peter J. F. M. Lohuis, Willem H. Schreuder, Ludi E. Smeele, Lilly-Ann van der Velden, I. Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V. Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S. Peeper, Ton N. Schumacher, Christian U. Blank, Jan Paul de Boer, John B. A. G. Haanen, Charlotte L. Zuur
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Immune checkpoint blockade has become standard care for patients with recurrent metastatic head and neck squamous cell carcinoma (HNSCC). Here the authors present the results of a non-randomized phase Ib/IIa trial, reporting safety and efficacy of ne
Externí odkaz:
https://doaj.org/article/761c20eac4bf4e0f8dc9495fdeadff61
Autor:
Marco J Koudijs, Marjo J den Broeder, Astrid Keijser, Erno Wienholds, Saskia Houwing, Ellen M H C van Rooijen, Robert Geisler, Fredericus J M van Eeden
Publikováno v:
PLoS Genetics, Vol 1, Iss 2, p e19 (2005)
Proliferation is one of the basic processes that control embryogenesis. To identify factors involved in the regulation of proliferation, we performed a zebrafish genetic screen in which we used proliferating cell nuclear antigen (PCNA) expression as
Externí odkaz:
https://doaj.org/article/8bd3adef8eab45dd81adedcc6ae2fdbb
Autor:
Harm van Tinteren, Kate Haslett, Astrid Keijser, Annija van der Leest, Egbert F. Smit, Bart Reymen, Matthew Hatton, Suresh Senan, Iris E. van Dam, Jos A. Stigt, Ben J. Slotman, J. Knegjens, Corinne Faivre-Finn, Devashish Tripathi, J. Praag
Publikováno v:
Lung Cancer, 108, 150-153. ELSEVIER IRELAND LTD
Lung Cancer, 108, 150-153. Elsevier Ireland Ltd
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150-153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J A, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150–153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Lung Cancer, 108, 150-153. Elsevier Ireland Ltd
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150-153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J A, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150–153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Introduction: In ES-SCLC patients with residual intrathoracic disease after first-line chemotherapy, the addition of thoracic radiotherapy reduces the risk of intrathoracic recurrence, and improves 2-year survival. To identify patient subgroups for f
Autor:
P.B. Olthof, C.J.A. Punt, K.P. van Lienden, T.M. van Gulik, M. G. H. van Oijen, J.H.W. de Wilt, Cees Verhoef, J. Huiskens, A. Rijken, Marc R. W. Engelbrecht, Gijs A. Patijn, M. Liem, T. Ruers, Michael F. Gerhards, Geert Kazemier, Astrid Keijser, John J. Hermans, Cornelius H. C. Dejong, I.Q. Molenaar, K. de Jong
Publikováno v:
HPB. 21:S802-S803
Publikováno v:
HPB. 18
Autor:
Sherif Y. El Sharouni, Ben J. Slotman, Matthew Hatton, Harm van Tinteren, Astrid Keijser, J. Knegjens, Suresh Senan, Corinne Faivre-Finn, J. Praag
Publikováno v:
Lancet, 384(9962), 36-42. Elsevier Limited
Lancet (UK), 385(9962), 36-42. Elsevier Ltd.
The Lancet, 384(9962), 36. Elsevier Limited
Slotman, B J, van Tinteren, H, Praag, J O, Knegjens, J L, El Sharouni, S Y, Hatton, M, de Keijser, A, Faivre-Finn, C & Senan, S 2015, ' Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial ', Lancet, vol. 384, no. 9962, pp. 36-42 . https://doi.org/10.1016/S0140-6736(14)61085-0
Lancet (UK), 385(9962), 36-42. Elsevier Ltd.
The Lancet, 384(9962), 36. Elsevier Limited
Slotman, B J, van Tinteren, H, Praag, J O, Knegjens, J L, El Sharouni, S Y, Hatton, M, de Keijser, A, Faivre-Finn, C & Senan, S 2015, ' Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial ', Lancet, vol. 384, no. 9962, pp. 36-42 . https://doi.org/10.1016/S0140-6736(14)61085-0
Summary Background Most patients with extensive stage small-cell lung cancer (ES-SCLC) who undergo chemotherapy, and prophylactic cranial irradiation, have persistent intrathoracic disease. We assessed thoracic radiotherapy for treatment of this pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1050c2caaff44c462437e8959a4b38a3
https://dspace.library.uu.nl/handle/1874/333005
https://dspace.library.uu.nl/handle/1874/333005
Autor:
Joost Huiskens, Thomas M. van Gulik, Cornelis J. A. Punt, Linda Mol, Marc R. W. Engelbrecht, Krijn P. van Lienden, Astrid Keijser, Geert Kazemier, Koert P. de Jong, I. Quintus Molenaar, Jonne Schriek, Nicole C.T. van Grieken, Cornelis Verhoef, Johanus H. W. de Wilt, T. Ruers, Harm van Tinteren, Kees C.H.C. Dejong, Gerrit A. Meijer
Publikováno v:
BMC Cancer, 15:365. BioMed Central
BMC Cancer, 15. BioMed Central Ltd.
Huiskens, J, van Gulik, T M, van Lienden, K P, Engelbrecht, M R W, Meijer, G A, van Grieken, N C T, van der Schriek, J, de Keijser, A, Mol, L, Molenaar, I Q, Verhoef, C, de Jong, K P, Dejong, K H C, Kazemier, G, Ruers, T M, de Wilt, J H W, van Tinteren, H & Punt, C J A 2015, ' Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG) ', BMC Cancer, vol. 15, 365 . https://doi.org/10.1186/s12885-015-1323-9
BMC cancer, 15(1). BioMed Central
BMC Cancer, 15
BMC Cancer, 15:365. BMC
BMC Cancer
BMC Cancer, 15. BioMed Central Ltd.
Huiskens, J, van Gulik, T M, van Lienden, K P, Engelbrecht, M R W, Meijer, G A, van Grieken, N C T, van der Schriek, J, de Keijser, A, Mol, L, Molenaar, I Q, Verhoef, C, de Jong, K P, Dejong, K H C, Kazemier, G, Ruers, T M, de Wilt, J H W, van Tinteren, H & Punt, C J A 2015, ' Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG) ', BMC Cancer, vol. 15, 365 . https://doi.org/10.1186/s12885-015-1323-9
BMC cancer, 15(1). BioMed Central
BMC Cancer, 15
BMC Cancer, 15:365. BMC
BMC Cancer
Contains fulltext : 154348.pdf (Publisher’s version ) (Open Access) BACKGROUND: Colorectal cancer patients with unresectable liver-only metastases may be cured after downsizing of metastases by neoadjuvant systemic therapy. However, the optimal neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b93ec611c2899e0ad54632724789cf9
https://research.vumc.nl/en/publications/ee03fde7-9277-4ddc-b6bf-fe4fb7f5c7c3
https://research.vumc.nl/en/publications/ee03fde7-9277-4ddc-b6bf-fe4fb7f5c7c3
Autor:
J. Knegjens, Berend J. Slotman, Astrid Keijser, Corinne Faivre-Finn, Egbert F. Smit, H. van Tinteren, D Tripathi, Matthew Hatton, J. Praag, Kate Haslett, Suresh Senan, I. van Dam, Jos A. Stigt, A. H. D. Van Der Leest, Bart Reymen
Publikováno v:
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E & Senan, S 2016, ' Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy ', International Journal of Radiation Oncology Biology Physics, vol. 96, no. 2, pp. S153-S154 .
International Journal of Radiation Oncology Biology Physics, 96(2), S153-S154. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics, 96(2), S153-S154. Elsevier Inc.
Autor:
Suresh Senan, Corinne Faivre-Finn, Sherif Y. El Sharouni, Harm van Tinteren, J. Praag, J. Knegjens, Ben J. Slotman, Matthew Hatton, Astrid Keijser
Publikováno v:
Slotman, B J, van Tinteren, H, Praag, J O, Knegjens, J L, El Sharouni, S Y, Hatton, M, Keijser, A, Faivre-Finn, C & Senan, S 2015, ' Radiotherapy for extensive stage small-cell lung cancer – Authors' reply ', Lancet, vol. 385, no. 9975, pp. 1292-1293 . https://doi.org/10.1016/S0140-6736(15)60679-1
Autor:
M. Snee, H. van Tinteren, P. Wilson, Corinne Faivre-Finn, S. Falk, A. Garcia, Astrid Keijser, Rhona McMenemin, Berend J. Slotman, A. Bates, Matthew Hatton, P. Jain, Clive Peedell, J. Ironside
Publikováno v:
Lung Cancer. 87:S60-S61